Switch View
© Globe Newswire
05.11.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London
News Preview
Media ReleaseCOPENHAGEN, Denmark; November 5, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan Van de Winkel and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Jefferies Global Healthcare Conference in London at 12:00 PM GMT (7:00 AM EST) on November 19, 2025. A webcast of the fir...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
Christian Mias wird Nachfolger von Andreas Reisse als CEO
News Preview
Der Aufsichtsrat der SCHOTT Pharma Management AG hat heute Dr. Christian Mias mit Wirkung zum 1. Mai 2026 zum neuen Chief Executive Officer (CEO) von SCHOTT Pharma bestellt. Er folgt auf Andreas Reisse, der planmäßig Ende April 2026 in den Ruhestand gehen wird. Dr. Christian Mias ist seit 2007 in verschiedenen Führungspositionen innerhalb der SCHOT......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.11.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
Christian Mias to succeed Andreas Reisse as CEO
News Preview
The Supervisory Board of SCHOTT Pharma Management AG has today appointed Christian Mias as the new Chief Executive Officer (CEO) of SCHOTT Pharma, effective May 1, 2026. He will succeed Andreas Reisse, who will retire as planned at the end of April 2026. Christian Mias has held various management positions within the SCHOTT Group since 2007, most r......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
05.11.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
SNDA Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Sonida Senior Living, Inc. is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Sonida Senior Living, Inc. (NYSE: SNDA) and CNL Healthcare Properties, Inc. is fair to Sonida shareholders. Upon completion of the proposed transaction, Sonida existing shareholders’ ownership would range from 39.5% to 50.0% of the newly combined company’s dilute...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
05.11.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Sobi to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary IC-MPGN and new outcome data on NASP at ASN Kidney Week
News Preview
STOCKHOLM, Nov. 5, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that data on Aspaveli/Empaveli in C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) and NASP in uncontrolled gout will be presented at ASN Kidney Week 2025, 5-9 November in Houston, Texas....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.11.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / November 5, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will participate in the following investor conferences:2025 UBS Global Healthcare Conference -...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: FR0012882389
Equasens
EQS
LISTED
EURONEXT
Equasens: Q3 2025 revenue
News Preview
Revenue at 30 September 2025: €172.2m
+8.9% on a reported basis and +7.3% like-for-like...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US0067391062
Addus Homecare Corp
ADUS
LISTED
NASDAQ
Addus HomeCare to Participate in Upcoming Investor Conferences in November
News Preview
Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in November:
2025 UBS Global Healthcare Conference in Palm Beach Gardens, Florida. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US2036681086
Community Health Systems Inc
CYH
LISTED
NYSE
Community Health Systems Announces Participation in the 2025 UBS Global Healthcare Conference
News Preview
Community Health Systems, Inc. (NYSE:CYH) today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference to be held November 10 - 12, 2025.
The fireside chat presentation will begin at 9:30 a.m. Eastern time, 8:30 a.m. Central time, on Tuesday, November 11, and will be available to investors via a live...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: AU0000054942
Imricor Medical Systems Inc.
IMR
LISTED
ASX
First in Human Ischemic VT Ablation Successfully Performed in iCMR
News Preview
Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the successful completion of the first Ischemic Ventricular Tachycardia (VT) ablation ever performed under real-time MRI guidance in an iCMR lab.
This press release features multimedia. View the f...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.11.2025
ISIN: CA92663R1055
Viemed Healthcare Inc
VMD
LISTED
NASDAQ
Viemed Healthcare Announces Third Quarter 2025 Financial Results
News Preview
LAFAYETTE, LA / ACCESS Newswire / November 5, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today that it has reported its financial results for the three and nine months ended...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US29350E2037
Lunai Bioworks Inc.
LNAI
LISTED
NASDAQ
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
News Preview
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines".
LOS ANGELES, Nov. 5, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthroug...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
05.11.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
News Preview
SALT LAKE CITY, Nov. 5, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented platform for developing advanced molecular diagnostic tests, today announced that it has engaged Maxim Group LLC ("Maxim") as its exclusive financial advisor...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US53228F1012
LifeStance Health Group Inc
LFST
LISTED
NASDAQ
Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season
News Preview
LifeStance Survey Reveals How the Holidays Affect Mental Health, with Stress and Social Pressure Hitting Millennials and Gen Z Hardest
SCOTTSDALE, Ariz., Nov. 5, 2025 /PRNewswire/ -- Findings from a LifeStance Health survey released today reveal that for many Am...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
News Preview
Completion of key step in IND transfer for upcoming Phase 2 breast cancer vaccine clinical trial
SAN JOSE, Calif., Nov. 5, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment an...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025. The meeting is taking place November 5 - 9 at the Gaylord National Convention Center in National...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare Announces $1.5 Million HCA Healthcare Foundation Grant to Support March of Dimes' Low Dose, Big Benefits™ Campaign
News Preview
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the HCA Healthcare Foundation, through its Healthier Tomorrow Fund, will strengthen its collaboration with March of Dimes, a leading nonprofit fighting for the health of all moms and babies, through a new $1.5 million grant to support their Low Dose,...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes
News Preview
New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by short-read sequencing technologies, positioning HiFi as the bridge between research and clinical-grade genomics New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by shor...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: KR7302440003
SK Bioscience Co Ltd
302440
LISTED
KOE
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025
News Preview
Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune therapeutics
Strengthening global CDMO strategy through strategic synergy with SK bioscience...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Quebec Expands Public Funding for CAPVAXIVE®
News Preview
KIRKLAND, QC, Nov. 5, 2025 /CNW/ -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the province of Quebec has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to their publicly funded adult immunization program. This addition makes the vaccine available...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
News Preview
SOUTH JORDAN, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive findings from the randomized AVF arm of the WAVE trial. These findings were presented during the Late-Breaking Clinical Trials session on Tuesday, November 4, 2025, at the Vascular In...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: KR7009290008
Kwang Dong Pharmaceutical Co., Ltd.
009290
LISTED
KOE
Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea
News Preview
Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that its partner, Zhaoke Ophthalmology Ltd. (“Zhaoke Ophthalmology”), a leading ophthalmic pharmaceutical company, has supported its South Korean partner, Kwangdong Pha...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs Reports Third Quarter 2025 Financial Results
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2025.
Third Quarter Highlights and Outlook (Unaudited)
Third quarter worldwide r...
Themefolio
Profiler
Peergroup
© Newsfile
05.11.2025
ISIN: CA14161Y2006
Cardiol Therapeutics Inc
CRDL
LISTED
TSX
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
News Preview
The ESC M&PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis.Presentation to provide comprehensive findings from the ARCHER trial following the reporting of topline results demonstrating a notable improvement in extracellular volume and a significant reduction in left ventricular mass...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: CA45074T1021
Ianthus Capital Holdings Inc.
IAN
LISTED
CSE
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers
News Preview
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
News Preview
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S....
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US45780L1044
Inogen Inc
INGN
LISTED
NASDAQ
Inogen Announces Third Quarter 2025 Financial Results
News Preview
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2025.
Recent Highlights
$92.4 million revenue, a year-over-year increase of 4.0%, marking the seventh consecutive quarter of mid-single-digit pe...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction Valued at Approximately $1.8 Billion, Creating $3 Billion Pure-Play Senior Housing Owner-Operator
News Preview
Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA), a leading owner, operator and investor in senior living communities, and CNL Healthcare Properties, Inc. (“CHP”), a public non-traded real estate investment trust (“REIT”) which owns a national portfolio of high-quality senior housing communities, today announced a definitive mer...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
News Preview
MaxCyte will now host its earnings conference call on November 12, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the third quarter ended September 30, 2025.
“The Viridian team continues to deliver stron...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed to Participate in Upcoming Investor Conferences
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
Stifel 2025 Healthcare Conference
Fo...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Provides Update on Strategic Review
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) today announced an update on its Board of Directors’ comprehensive strategic review of the Company’s business and growth prospects. The Board strongly supports the Company’s strategic direction and believes it should continue to focus on strengthening its leading scientific portfolio withi...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
MANNKIND CORPORATION REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US52635N1037
LENZ Therapeutics Inc
LENZ
LISTED
NASDAQ
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
News Preview
VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the treatment of presbyopia...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US74006W1080
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results
News Preview
Announced positive results from two pivotal Phase 3 Essential3 studies of ulixacaltamide HCl in essential tremor (ET); Pre-NDA meeting with FDA scheduled for Q4 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: NL00150012L7
NewAmsterdam Pharma Company N.V.
NAMS
LISTED
NASDAQ
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
News Preview
– Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency –...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside chat at each of the following upcoming investor conferences:
Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025, at 8:40 a.m. EST
Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025, at 1:...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Announces Third-Quarter 2025 Results
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2025. For the quarter, revenue was $1.00 billion, a decrease of 0.5% from $1.01 billion in the third quarter of 2024.
The impact of foreign currency translation increased reported revenue by 1.3%, and the divestiture of a small Safety As...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US3741631036
Geron Corp
GERN
LISTED
NASDAQ
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today reported financial results for the third quarter of 2025 and recent business highlights.
"The high unmet need in lower-risk MDS is well known, and RYTELO is a therapy with a novel mechanism of action...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US52886X1072
Lexeo Therapeutics Inc
LXEO
LISTED
NASDAQ
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
News Preview
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US09073M1045
Bio-Techne Corp
TECH
LISTED
NASDAQ
BIO-TECHNE DECLARES DIVIDEND
News Preview
MINNEAPOLIS, Nov. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2025. The quarterly dividend will be payable November 28, 2025, to all common shareholders of record on Novembe...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Announces Third Quarter 2025 Financial Results
News Preview
Third quarter net sales of $2.001 billion increased 9.7% on a reported basis, 8.6% on a constant currency1 basis and 5.0% on an organic constant currency1 basis
Third quarter diluted earnings per share were $1.16; adjusted1 diluted earnings per share were $1.90, an increase of 9.2%...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US57055L1070
Marker Therapeutics, Inc.
MRKR
LISTED
NASDAQ
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
News Preview
HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced the appointment of Kathryn Penkus Corzo, R.Ph., MBA to the Co...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US76200L3096
Rezolute, Inc.
RZLT
LISTED
NASDAQ
Rezolute to Host Virtual Investor Event on Ersodetug Development Program
News Preview
Webcast scheduled for Monday, November 10 at 12:00 pm EST Webcast scheduled for Monday, November 10 at 12:00 pm EST...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: KYG2545C1042
Crescent Biopharma, Inc.
CBIO
LISTED
NASDAQ
Crescent Biopharma to Present at November Investor Conferences
News Preview
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November:...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune to Participate in Two Upcoming Investor Conferences
News Preview
GAITHERSBURG, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the Company’s management team will participate and be available for one-on-one meetings at the follo...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US20454B1044
Compass Therapeutics Inc.
CMPX
LISTED
NASDAQ
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today reported third quarter 2025 financial results and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: IL0011316309
Mediwound Ltd
MDWD
LISTED
NASDAQ
MediWound to Report Third Quarter 2025 Financial Results
News Preview
MediWound to Report Third Quarter 2025 Financial Results...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US03073E1055
Cencora Inc
COR
LISTED
NYSE
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results
News Preview
Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2025 fourth quarter ended September 30, 2025, revenue increased 5.9 percent to $83.7 billion. Revenue increased 9.3 percent to $321.3 billion for fiscal year 2025. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $(1.75) for t...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: CA22587M1068
Cresco Labs Inc
CL
LISTED
CSE
Cresco Labs Delivers Strong Q3, Maintains Market Leadership, and Unlocks New Growth Opportunities
News Preview
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2025. All financial inform...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US92337R1014
Vera Therapeutics Inc
VERA
LISTED
NASDAQ
Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
News Preview
Vera Therapeutics today reported its business highlights and financial results for the third quarter ended September 30, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: US28414H1032
Elanco Animal Health Inc
ELAN
LISTED
NYSE
Elanco Animal Health Reports Third Quarter 2025 Results
News Preview
Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target
Third Quarter
2025 Financial Results:...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: CA89788C1041
Trulieve Cannabis Corp
TRUL
LISTED
CSE
Trulieve Reports Third Quarter 2025 Results Demonstrating Operational Discipline and Cash Flow Strength
News Preview
Third quarter revenue of $288 million, with 59% gross margin
Year to date cash flow from operations of $214 million and free cash flow of $173 million*
Sold over 12.5 million branded products in the third quarter, up 7% compared to last year...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ISIN: CA89788C1041
Trulieve Cannabis Corp
TRUL
LISTED
CSE
Trulieve Reports Third Quarter 2025 Results Demonstrating Operational Discipline and Cash Flow Strength
News Preview
Third quarter revenue of $288 million, with 59% gross margin
Year to date cash flow from operations of $214 million and free cash flow of $173 million*
Sold over 12.5 million branded products in the third quarter, up 7% compared to last year...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
News Preview
ZUG, Switzerland, November 5, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on advancing therapies to address significant unmet needs in inflammatory skin and joint diseases, today announced the pricing of an underwritten offering of 7,142,857 Class A ordinary shares at an offering pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US83086J2006
Skye Bioscience Inc
SKYE
LISTED
NASDAQ
Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain
News Preview
During 12-week post-treatment period, nimacimab plus semaglutide blunts weight regain compared to semaglutide alone in subset analysis During 12-week post-treatment period, nimacimab plus semaglutide blunts weight regain compared to semaglutide alone in subset analysis...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US0352551081
Anika Therapeutics Inc
ANIK
LISTED
NASDAQ
Anika Reports Third Quarter 2025 Financial Results
News Preview
Commercial Channel revenue up 22% with continued strong Integrity™ Implant System and Hyalofast® growth, and double-digit International OA Pain Management growth...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call
News Preview
MINNEAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, November 12, 2025. Management will host a webcast/t...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US47973J1025
Joint Corp
JYNT
LISTED
NASDAQ
The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program
News Preview
SCOTTSDALE, Ariz., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that its board of directors has authorized an additional $12 million for its stock repurchase program....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US09058V1035
BioCryst Pharmaceuticals Inc
BCRX
LISTED
NASDAQ
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
RESEARCH TRIANGLE PARK, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted three newly-hired employees restricted stock units (RSUs) covering an aggregate of 30,700 shares of BioCryst common stock. The RSUs were granted as o...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
